GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.
GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.
复制标题
DOI:
10.1073/pnas.2108079118
复制
发表时间:
2021-08-03
影响因子:
11.1
通讯作者:
Wellendorph P
中科院分区:
文献类型:
--
作者:
Leurs U;Klein AB;McSpadden ED;Griem-Krey N;Solbak SMØ;Houlton J;Villumsen IS;Vogensen SB;Hamborg L;Gauger SJ;Palmelund LB;Larsen ASG;Shehata MA;Kelstrup CD;Olsen JV;Bach A;Burnie RO;Kerr DS;Gowing EK;Teurlings SMW;Chi CC;Gee CL;Frølund B;Kornum BR;van Woerden GM;Clausen RP;Kuriyan J;Clarkson AN;Wellendorph P
GHB is a natural brain metabolite of GABA, previously reported to be neuroprotective. However, the high-affinity binding site for GHB has remained elusive for almost 40 y. We here unveil CaMKIIα, a highly important neuronal kinase, as the long-sought-after GHB high-affinity target. Via a specific interaction within the central hub domain of CaMKIIα, GHB analogs act to stabilize the hub oligomer complex. This interaction potentially explains pronounced neuroprotective effects of GHB analogs in cultured neurons exposed to a chemical insult and in mice exposed to ischemia. The postischemic treatment effects of GHB analogs underline these compounds as selective and high-affinity potential drug candidates and CaMKIIα as a relevant pharmacological target for stroke therapy. Ca2+/calmodulin-dependent protein kinase II alpha subunit (CaMKIIα) is a key neuronal signaling protein and an emerging drug target. The central hub domain regulates the activity of CaMKIIα by organizing the holoenzyme complex into functional oligomers, yet pharmacological modulation of the hub domain has never been demonstrated. Here, using a combination of photoaffinity labeling and chemical proteomics, we show that compounds related to the natural substance γ-hydroxybutyrate (GHB) bind selectively to CaMKIIα. By means of a 2.2-Å x-ray crystal structure of ligand-bound CaMKIIα hub, we reveal the molecular details of the binding site deep within the hub. Furthermore, we show that binding of GHB and related analogs to this site promotes concentration-dependent increases in hub thermal stability believed to alter holoenzyme functionality. Selectively under states of pathological CaMKIIα activation, hub ligands provide a significant and sustained neuroprotection, which is both time and dose dependent. This is demonstrated in neurons exposed to excitotoxicity and in a mouse model of cerebral ischemia with the selective GHB analog, HOCPCA (3-hydroxycyclopent-1-enecarboxylic acid). Together, our results indicate a hitherto unknown mechanism for neuroprotection by a highly specific and unforeseen interaction between the CaMKIIα hub domain and small molecule brain-penetrant GHB analogs. This establishes GHB analogs as powerful tools for investigating CaMKII neuropharmacology in general and as potential therapeutic compounds for cerebral ischemia in particular.
登录
查看更多内容
影响因子:
8.2
作者:
Coultrap, Steven J.;Vest, Rebekah S.;Ashpole, Nicole M.;Hudmon, Andy;Bayer, K. Ulrich
通讯作者:
Bayer, K. Ulrich
影响因子:
7.7
作者:
Karandur D;Bhattacharyya M;Xia Z;Lee YK;Muratcioglu S;McAffee D;McSpadden ED;Qiu B;Groves JT;Williams ER;Kuriyan J
通讯作者:
Kuriyan J
影响因子:
56.9
作者:
De Koninck, P;Schulman, H
通讯作者:
Schulman, H
影响因子:
7.2
作者:
Bhattacharyya, Moitrayee;Karandur, Deepti;Kuriyan, John
通讯作者:
Kuriyan, John
影响因子:
7.7
作者:
Chia PH;Zhong FL;Niwa S;Bonnard C;Utami KH;Zeng R;Lee H;Eskin A;Nelson SF;Xie WH;Al-Tawalbeh S;El-Khateeb M;Shboul M;Pouladi MA;Al-Raqad M;Reversade B
通讯作者:
Reversade B